The Global Cell and Gene Therapy Manufacturing Quality Control Market Size was estimated at USD 476.99 million in 2023 and is projected to reach USD 1354.54 million by 2029, exhibiting a CAGR of 19.00% during the forecast period.
Report Overview:
This report provides a deep insight into the global Cell and Gene Therapy Manufacturing Quality Control market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell and Gene Therapy Manufacturing Quality Control Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell and Gene Therapy Manufacturing Quality Control market in any manner.
Global Cell and Gene Therapy Manufacturing Quality Control Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Bio-Rad Laboratories,Inc.
- QIAGEN
- Charles River Laboratories International, Inc.
- Lonza Group AG
- Bio-Techne Corporation
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific, Inc.
- Intertek Group Plc
- Eurofins Scientific S.E.
Market Segmentation (by Type)
- Sterility Testing
- Purity Testing
- Potency Testing
- Identity Testing
- Others
Market Segmentation (by Application)
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cell and Gene Therapy Manufacturing Quality Control Market
- Overview of the regional outlook of the Cell and Gene Therapy Manufacturing Quality Control Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy Manufacturing Quality Control Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cell and Gene Therapy Manufacturing Quality Control
1.2 Key Market Segments
1.2.1 Cell and Gene Therapy Manufacturing Quality Control Segment by Type
1.2.2 Cell and Gene Therapy Manufacturing Quality Control Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cell and Gene Therapy Manufacturing Quality Control Market Overview
2.1 Global Market Overview
2.1.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell and Gene Therapy Manufacturing Quality Control Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cell and Gene Therapy Manufacturing Quality Control Market Competitive Landscape
3.1 Global Cell and Gene Therapy Manufacturing Quality Control Sales by Manufacturers (2019-2024)
3.2 Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell and Gene Therapy Manufacturing Quality Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell and Gene Therapy Manufacturing Quality Control Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell and Gene Therapy Manufacturing Quality Control Sales Sites, Area Served, Product Type
3.6 Cell and Gene Therapy Manufacturing Quality Control Market Competitive Situation and Trends
3.6.1 Cell and Gene Therapy Manufacturing Quality Control Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell and Gene Therapy Manufacturing Quality Control Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cell and Gene Therapy Manufacturing Quality Control Industry Chain Analysis
4.1 Cell and Gene Therapy Manufacturing Quality Control Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cell and Gene Therapy Manufacturing Quality Control Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cell and Gene Therapy Manufacturing Quality Control Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Type (2019-2024)
6.3 Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2019-2024)
6.4 Global Cell and Gene Therapy Manufacturing Quality Control Price by Type (2019-2024)
7 Cell and Gene Therapy Manufacturing Quality Control Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Sales by Application (2019-2024)
7.3 Global Cell and Gene Therapy Manufacturing Quality Control Market Size (M USD) by Application (2019-2024)
7.4 Global Cell and Gene Therapy Manufacturing Quality Control Sales Growth Rate by Application (2019-2024)
8 Cell and Gene Therapy Manufacturing Quality Control Market Segmentation by Region
8.1 Global Cell and Gene Therapy Manufacturing Quality Control Sales by Region
8.1.1 Global Cell and Gene Therapy Manufacturing Quality Control Sales by Region
8.1.2 Global Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Region
8.2 North America
8.2.1 North America Cell and Gene Therapy Manufacturing Quality Control Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell and Gene Therapy Manufacturing Quality Control Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell and Gene Therapy Manufacturing Quality Control Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell and Gene Therapy Manufacturing Quality Control Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bio-Rad Laboratories,Inc.
9.1.1 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Basic Information
9.1.2 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product Overview
9.1.3 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product Market Performance
9.1.4 Bio-Rad Laboratories,Inc. Business Overview
9.1.5 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control SWOT Analysis
9.1.6 Bio-Rad Laboratories,Inc. Recent Developments
9.2 QIAGEN
9.2.1 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Basic Information
9.2.2 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product Overview
9.2.3 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product Market Performance
9.2.4 QIAGEN Business Overview
9.2.5 QIAGEN Cell and Gene Therapy Manufacturing Quality Control SWOT Analysis
9.2.6 QIAGEN Recent Developments
9.3 Charles River Laboratories International, Inc.
9.3.1 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Basic Information
9.3.2 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Overview
9.3.3 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Market Performance
9.3.4 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control SWOT Analysis
9.3.5 Charles River Laboratories International, Inc. Business Overview
9.3.6 Charles River Laboratories International, Inc. Recent Developments
9.4 Lonza Group AG
9.4.1 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Basic Information
9.4.2 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product Overview
9.4.3 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product Market Performance
9.4.4 Lonza Group AG Business Overview
9.4.5 Lonza Group AG Recent Developments
9.5 Bio-Techne Corporation
9.5.1 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Basic Information
9.5.2 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product Overview
9.5.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product Market Performance
9.5.4 Bio-Techne Corporation Business Overview
9.5.5 Bio-Techne Corporation Recent Developments
9.6 Merck KGaA
9.6.1 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Basic Information
9.6.2 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product Overview
9.6.3 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product Market Performance
9.6.4 Merck KGaA Business Overview
9.6.5 Merck KGaA Recent Developments
9.7 F. Hoffmann-La Roche Ltd
9.7.1 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Basic Information
9.7.2 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product Overview
9.7.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product Market Performance
9.7.4 F. Hoffmann-La Roche Ltd Business Overview
9.7.5 F. Hoffmann-La Roche Ltd Recent Developments
9.8 Thermo Fisher Scientific, Inc.
9.8.1 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Basic Information
9.8.2 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Overview
9.8.3 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Market Performance
9.8.4 Thermo Fisher Scientific, Inc. Business Overview
9.8.5 Thermo Fisher Scientific, Inc. Recent Developments
9.9 Intertek Group Plc
9.9.1 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Basic Information
9.9.2 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product Overview
9.9.3 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product Market Performance
9.9.4 Intertek Group Plc Business Overview
9.9.5 Intertek Group Plc Recent Developments
9.10 Eurofins Scientific S.E.
9.10.1 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Basic Information
9.10.2 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product Overview
9.10.3 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product Market Performance
9.10.4 Eurofins Scientific S.E. Business Overview
9.10.5 Eurofins Scientific S.E. Recent Developments
10 Cell and Gene Therapy Manufacturing Quality Control Market Forecast by Region
10.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast
10.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Country
10.2.3 Asia Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Region
10.2.4 South America Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell and Gene Therapy Manufacturing Quality Control by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell and Gene Therapy Manufacturing Quality Control by Type (2025-2030)
11.1.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell and Gene Therapy Manufacturing Quality Control by Type (2025-2030)
11.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Forecast by Application (2025-2030)
11.2.1 Global Cell and Gene Therapy Manufacturing Quality Control Sales (K Units) Forecast by Application
11.2.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell and Gene Therapy Manufacturing Quality Control Market Size Comparison by Region (M USD)
Table 5. Global Cell and Gene Therapy Manufacturing Quality Control Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell and Gene Therapy Manufacturing Quality Control Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Quality Control as of 2022)
Table 10. Global Market Cell and Gene Therapy Manufacturing Quality Control Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell and Gene Therapy Manufacturing Quality Control Sales Sites and Area Served
Table 12. Manufacturers Cell and Gene Therapy Manufacturing Quality Control Product Type
Table 13. Global Cell and Gene Therapy Manufacturing Quality Control Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell and Gene Therapy Manufacturing Quality Control
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell and Gene Therapy Manufacturing Quality Control Market Challenges
Table 22. Global Cell and Gene Therapy Manufacturing Quality Control Sales by Type (K Units)
Table 23. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (M USD)
Table 24. Global Cell and Gene Therapy Manufacturing Quality Control Sales (K Units) by Type (2019-2024)
Table 25. Global Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Type (2019-2024)
Table 26. Global Cell and Gene Therapy Manufacturing Quality Control Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Share by Type (2019-2024)
Table 28. Global Cell and Gene Therapy Manufacturing Quality Control Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell and Gene Therapy Manufacturing Quality Control Sales (K Units) by Application
Table 30. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
Table 31. Global Cell and Gene Therapy Manufacturing Quality Control Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Application (2019-2024)
Table 33. Global Cell and Gene Therapy Manufacturing Quality Control Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2019-2024)
Table 35. Global Cell and Gene Therapy Manufacturing Quality Control Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell and Gene Therapy Manufacturing Quality Control Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Region (2019-2024)
Table 38. North America Cell and Gene Therapy Manufacturing Quality Control Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell and Gene Therapy Manufacturing Quality Control Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell and Gene Therapy Manufacturing Quality Control Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell and Gene Therapy Manufacturing Quality Control Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control Sales by Region (2019-2024) & (K Units)
Table 43. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Basic Information
Table 44. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product Overview
Table 45. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Bio-Rad Laboratories,Inc. Business Overview
Table 47. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control SWOT Analysis
Table 48. Bio-Rad Laboratories,Inc. Recent Developments
Table 49. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Basic Information
Table 50. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product Overview
Table 51. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. QIAGEN Business Overview
Table 53. QIAGEN Cell and Gene Therapy Manufacturing Quality Control SWOT Analysis
Table 54. QIAGEN Recent Developments
Table 55. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Basic Information
Table 56. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Overview
Table 57. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control SWOT Analysis
Table 59. Charles River Laboratories International, Inc. Business Overview
Table 60. Charles River Laboratories International, Inc. Recent Developments
Table 61. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Basic Information
Table 62. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product Overview
Table 63. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Lonza Group AG Business Overview
Table 65. Lonza Group AG Recent Developments
Table 66. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Basic Information
Table 67. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product Overview
Table 68. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bio-Techne Corporation Business Overview
Table 70. Bio-Techne Corporation Recent Developments
Table 71. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Basic Information
Table 72. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product Overview
Table 73. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Merck KGaA Business Overview
Table 75. Merck KGaA Recent Developments
Table 76. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Basic Information
Table 77. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product Overview
Table 78. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. F. Hoffmann-La Roche Ltd Business Overview
Table 80. F. Hoffmann-La Roche Ltd Recent Developments
Table 81. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Basic Information
Table 82. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Overview
Table 83. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Thermo Fisher Scientific, Inc. Business Overview
Table 85. Thermo Fisher Scientific, Inc. Recent Developments
Table 86. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Basic Information
Table 87. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product Overview
Table 88. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Intertek Group Plc Business Overview
Table 90. Intertek Group Plc Recent Developments
Table 91. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Basic Information
Table 92. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product Overview
Table 93. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Eurofins Scientific S.E. Business Overview
Table 95. Eurofins Scientific S.E. Recent Developments
Table 96. Global Cell and Gene Therapy Manufacturing Quality Control Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Cell and Gene Therapy Manufacturing Quality Control Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Cell and Gene Therapy Manufacturing Quality Control Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Cell and Gene Therapy Manufacturing Quality Control Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Cell and Gene Therapy Manufacturing Quality Control Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Cell and Gene Therapy Manufacturing Quality Control Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Cell and Gene Therapy Manufacturing Quality Control Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Cell and Gene Therapy Manufacturing Quality Control Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Cell and Gene Therapy Manufacturing Quality Control
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy Manufacturing Quality Control Market Size (M USD), 2019-2030
Figure 5. Global Cell and Gene Therapy Manufacturing Quality Control Market Size (M USD) (2019-2030)
Figure 6. Global Cell and Gene Therapy Manufacturing Quality Control Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (M USD)
Figure 11. Cell and Gene Therapy Manufacturing Quality Control Sales Share by Manufacturers in 2023
Figure 12. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Share by Manufacturers in 2023
Figure 13. Cell and Gene Therapy Manufacturing Quality Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell and Gene Therapy Manufacturing Quality Control Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy Manufacturing Quality Control Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Type
Figure 18. Sales Market Share of Cell and Gene Therapy Manufacturing Quality Control by Type (2019-2024)
Figure 19. Sales Market Share of Cell and Gene Therapy Manufacturing Quality Control by Type in 2023
Figure 20. Market Size Share of Cell and Gene Therapy Manufacturing Quality Control by Type (2019-2024)
Figure 21. Market Size Market Share of Cell and Gene Therapy Manufacturing Quality Control by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Application
Figure 24. Global Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Application (2019-2024)
Figure 25. Global Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Application in 2023
Figure 26. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2019-2024)
Figure 27. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Application in 2023
Figure 28. Global Cell and Gene Therapy Manufacturing Quality Control Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Region (2019-2024)
Figure 30. North America Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Country in 2023
Figure 32. U.S. Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell and Gene Therapy Manufacturing Quality Control Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell and Gene Therapy Manufacturing Quality Control Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Country in 2023
Figure 37. Germany Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Region in 2023
Figure 44. China Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (K Units)
Figure 50. South America Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Country in 2023
Figure 51. Brazil Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell and Gene Therapy Manufacturing Quality Control Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell and Gene Therapy Manufacturing Quality Control Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cell and Gene Therapy Manufacturing Quality Control Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cell and Gene Therapy Manufacturing Quality Control Market Share Forecast by Type (2025-2030)
Figure 65. Global Cell and Gene Therapy Manufacturing Quality Control Sales Forecast by Application (2025-2030)
Figure 66. Global Cell and Gene Therapy Manufacturing Quality Control Market Share Forecast by Application (2025-2030)
